[HTML] thelancet.com

[HTML][HTML] mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective …

SF Oosting, AAM van der Veldt… - The Lancet …, 2021 - thelancet.com
Background Patients with cancer have an increased risk of complications from SARS-CoV-2
infection. Vaccination to prevent COVID-19 is recommended, but data on the …
被引用次数：154 相关文章

mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non …

SF Oosting, AAM van der Veldt, CH GeurtsvanKessel… - 2021 - cabidigitallibrary.org
Background: Patients with cancer have an increased risk of complications from SARS-CoV-2
infection. Vaccination to prevent COVID-19 is recommended, but data on the …

mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non …

SF Oosting, AAM van der Veldt… - The Lancet …, 2021 - Elsevier
Background Patients with cancer have an increased risk of complications from SARS-CoV-2
infection. Vaccination to prevent COVID-19 is recommended, but data on the …

mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non …

SF Oosting, AAM van der Veldt… - Lancet …, 2021 - research.rug.nl
BACKGROUND: Patients with cancer have an increased risk of complications from SARS-
CoV-2 infection. Vaccination to prevent COVID-19 is recommended, but data on the …

mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non …

SF Oosting, AAM van der Veldt… - The Lancet …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Patients with cancer have an increased risk of complications from SARS-CoV-2
infection. Vaccination to prevent COVID-19 is recommended, but data on the …
[HTML] nih.gov

[HTML][HTML] mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective …

SF Oosting, AAM van der Veldt… - The Lancet …, 2021 - ncbi.nlm.nih.gov
Background Patients with cancer have an increased risk of complications from SARS-CoV-2
infection. Vaccination to prevent COVID-19 is recommended, but data on the …

mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non …

SF Oosting, AAM van der Veldt… - The Lancet …, 2021 - europepmc.org
Background Patients with cancer have an increased risk of complications from SARS-CoV-2
infection. Vaccination to prevent COVID-19 is recommended, but data on the …

[引用][C] mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre …

SF Oosting, AAM van der Veldt… - The Lancet …, 2021 - cir.nii.ac.jp
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or
chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial | CiNii …

[引用][C] mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre …

S Oosting, A van der Veldt… - Lancet …, 2021 - elib.tiho-hannover.de
mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or
chemoimmunotherapy for solid tumours: a prospective, multicentre, non-inferiority trial …

mRNA-1273 COVID-19 vaccination in patients receiving chemotherapy, immunotherapy, or chemoimmunotherapy for solid tumours: a prospective, multicentre, non …

SF Oosting, AAM van der Veldt… - The Lancet …, 2021 - europepmc.org
Background Patients with cancer have an increased risk of complications from SARS-CoV-2
infection. Vaccination to prevent COVID-19 is recommended, but data on the …